Nadine Al-naamani - Faculty Biosketch

Nadine Al-Naamani, MD, MS

Assistant Professor of Medicine (Pulmonary, Allergy and Critical Care) at the Hospital of the University of Pennsylvania

Attending physician, Penn Medicine Rittenhouse Long-Term Acute Care Hospital

Attending physician, Hospital of the University of Pennsylvania

Attending physician, Penn Presbyterian Medical Center

Program Director of the Adult Center for Human Phenomic Science (CHPS) , University of Pennsylvania's Center for Human Phenomic Science (CHPS)

Department: Medicine

Contact information

9021 Gates Building
3600 Spruce Street
Philadelphia, PA 19104

Publications

Search PubMed for articles

Education:
BS (Chemistry)
American University of Beirut, 1999.
MD (Medicine)
American University of Beirut, 2003.
MS (Clinical and Translational Science)
Sackler School of Graduate Biomedical Sciences at Tufts University, 2016.

Links
Search PubMed for articles

Post-Graduate Training
Internship and Residency, Internal Medicine, American University of Beirut, 2003-2006.
Postdoctoral Research Scientist, Pulmonary, Allergy and Critical Care Medicine, Columbia University College of Physicians and Surgeons, 2006-2008.
Internship, Internal Medicine, St. Luke's Roosevelt Hospital, 2008-2009.
Residency, Internal Medicine, St. Luke's Roosevelt Hospital, 2009-2010.
Residency, Medicine, Cambridge Health Alliance, 2010-2011.
Fellowship, Pulmonary and Critical Care Medicine, Tufts Medical Center, 2011-2014.
Fellowship, Comparative Effectiveness Research, Tufts Clinical and Translational Science Institute, 2014-2016.

Certifications
Permanent Certificate, Educational Commission on Foreign Medical Graduates, 2007.
American Board of Internal Medicine, Internal Medicine, 2011.
American Board of Internal Medicine, Pulmonary Disease, 2013.
Basic Life Support (BLS) Provider, 2014.
Advanced Cardiovascular Life Support (ACLS) Provider, 2014.
American Board of Internal Medicine, Critical Care, 2014.

Permanent link

> Perelman School of Medicine > Faculty > Details

Description of Research Expertise

Pulmonary vascular disease research

Selected Publications

B.E. McCarthy, R. Feng, R. Bernardo, O. Shlobin, T. De Marco, T. Wichman, K.W. Presberg, A. Ravichandran, E. Horn, J.M. Elwing, M.P. George, J.R. Runo, Z. Safdar, C.E. Ventetuolo, N. Al-Naamani: Impact of Insurance Type on Treatment Patterns in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry. American Thoracic Society International Conference, San Francisco CA May 2025.

M.R. Anderson, D. Anderson, M. Kreider, N. Al-Naamani, J. Diamond, J.D. Christie, Y. Cao: The Prevalence of Obesity and Obesity Complications in Patients With ILD: Analysis of National Electronic Medical Record Data. American Thoracic Society International Conference, San Francisco CA May 2025.

R. Reddy, J. Moutchia, A. Ravichandran, J.R. Runo, D.B. Badesch, J.E. Moss, C.D. Burger, T. De Marco, E. Horn, A. Ataya, A.J. Bryant, N. Al-Naamani, S.M. Kawut: Pulmonary Arterial Hypertension in Octogenarians: The Pulmonary Hypertension Association Registry. American Thoracic Society International Conference, San Francisco CA May 2025.

C. Asiegbu, M. Batson, N. Al-Naamani, S. Pugliese, J.S. Fritz, H.I. Palevsky, K.A. Smith, J. Moutchia, S.M. Kawut, J. Minhas: Physical Frailty in Pulmonary Arterial Hypertension (PAH) - Exploring Sociodemographic and Clinical Associations With Physical Activity. American Thoracic Society International Conference, San Francisco CA May 2025.

J. Minhas, H. Shou, C.E. Ventetuolo, T.M. Bull, A.R. Hemnes, M.M. Chakinala, S.C. Mathai, R.T. Zamanian, N. Al-Naamani, S.M. Kawut: Remote Monitoring of Physical Activity in Randomized Clinical Trial of Anastrozole in PAH - The PHANTOM Study. American Thoracic Society International Conference, San Francisco CA May 2025.

Z. Dunfesky, S.M. Kawut, S. Pugliese, K.A. Smith, J.S. Fritz, J. Minhas, H.I. Palevsky, Y. Tong, D. Torigian, J. Udupa, N. Al-Naamani: Low Muscle Mass In Patients With Pulmonary Arterial Hypertension. American Thoracic Society International Conference, San Francisco CA May 2025.

S. Aijaz, K. Cox-Flaherty, G. Baird, J.R. Klinger, C.J. Mullin, N. Singh, M.E. Whittenhall, A. Jorrin, M. Atalay, N. Al-Naamani, C.E. Ventetuolo: Paracardial Adipose Tissue and Right Ventricular Dysfunction in Pulmonary Arterial Hypertension. American Thoracic Society International Conference, San Francisco CA May 2025.

Sridhar M, Tauquir A, Sahay S, Tonelli AR, Al-Naamani N, and Cajigas HR: Frailty in Pulmonary Hypertension: A Multidimensional Comorbidity. Ann Am Thorac Soc April 2025.

Handoko, ML, Moutchia, J, Al-Naamani, N, Holmes, JH, de Man, FS, Reddy, YN, Borlaug, BA, Kawut, SM: Effect of PAH-Specific Treatment is Marginally Modified by Predicted HFpEF Probability: An Individual Participant Data Meta-Analysis. International Society for Heart and Lung Transplantation Conference April 2025 Notes: poster presentation.

Minhas, JK, Al-Naamani, N: Treprostinil in Pulmonary Arterial Hypertension With Cardiovascular Comorbidities: To Use or Avoid. Chest Page: epub ahead of print, Jan 2025.